Skip to main content

Missing the NIH

Had the drug trial not been shut down, right now I would have been at the NIH for my three-year follow up. It feels so strange to not be at the NIH. I hesitate to say this too loudly for fear someone think I’m a little crazy, but I think I’m not alone. We develop a certain sentimental attachment to the place. Although I know I’ll be back someday, I was looking forward to the trip. I was looking forward to seeing my HPS friends. I was looking forward to seeing all my favorite nurses. And of course, to seeing all my favorite doctors. In many ways I have a better social life at the NIH than I do at home!

I was actually looking forward to the more extensive tests a three-year follow up would have brought. Although my PFTs are still pretty good, they had fallen last November and hadn’t improved again since. I wanted to know what a CT scan revealed. I liked going back every four months because it was so reassuring to how I was really doing. It’s unlikely anything huge would change in four months, thus any downward movement was sort of broken to you gently. When you only go back every few years, you know in the back of your brain that so much could have changed – you sort of go waiting for that bomb to be dropped that you know is going to alter your life forever.

I also just felt very physiologically safe at the NIH. I don’t have to explain anything to anyone there. I know they know. When I was working, it wasn’t easy going, but at the same time, I looked forward to the visits. I’d be so stressed trying to be ready for the work that I missed; I’d usually show up somewhat under the weather. Being at the NIH with others taking care of me gave me a chance to recharge my batteries. When you’re in “the hospital” no one bothers you much. I had a few days where I didn’t have to compartmentalize my emotions between the HPS world and the world of everyone else. I guess I felt a sense of protection there that’s hard to explain to others.

I guess these were the unintended side effects of participating in the clinical trial. I know the folks at NIH would have my back if I needed them, but it doesn’t replace seeing them.

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for...

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria...